ScreenerHero

SCPSScopus BioPharma Inc.

NAS · US · Healthcare · Biotechnology · scopusbiopharma.com
0.0004USD0.00%Mkt Cap: 16833 $P/E: —

Scopus BioPharma Inc., a clinical-stage biopharmaceutical company, focuses on developing transformational therapeutics targeting serious diseases with unmet medical needs. It offers Duet Platform, which consists of signa…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$138.82BUSDP/E 31.9
REGN
Regeneron Pharmaceuticals, Inc.
$85.87BUSDP/E 20.5
ARGX
ARGENX SE
$61.34BUSDP/E 39.8
ARGX
argenx SE
$65.05BUSDP/E 39.6
MRNA
Moderna, Inc.
$57.94BUSD
UCB
UCB SA
$45.95BUSDP/E 19.6
RVMD
Revolution Medicines, Inc.
$44.89BUSD
ONC
BeOne Medicines AG
$42.36BUSDP/E 67.2
RPRX
Royalty Pharma Plc Class A
$35.43BUSDP/E 32.6
ALNY
Alnylam Pharmaceuticals, Inc.
$31.61BUSDP/E 41.2
BNTX
BioNTech SE
$29.28BUSD
INSM
Insmed Incorporated
$27.47BUSD
ROIV
Roivant Sciences Ltd. Common Shares
$26.22BUSD
INCY
Incyte Corporation
$25.91BUSDP/E 16.2
GMAB
Genmab A/S
$20.86BUSDP/E 26.3
GMAB
Genmab A/S
$19.26BUSDP/E 26.6
ASND
Ascendis Pharma A/S
$16.61BUSDP/E 19.6
JAZZ
Jazz Pharmaceuticals plc
$16.51BUSDP/E 17.4
BBIO
BridgeBio Pharma, Inc.
$15.93BUSD
EXEL
Exelixis, Inc.
$13.40BUSDP/E 17.0

Key Statistics

Company
Market Cap16.83K $
Enterprise Value-1.40M $
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-11.61M $
Revenue/Share—
Last Price0.0004 USD
Fiscal Year EndDec 2022
MR QuarterJun 2023
Employees13
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-0.00
PEG—
EV/EBITDA0.15
EV/Revenue—
P/S—
P/B-0.00
EPS (TTM)-0.41
EPS (Forward)-1.23
52W Range
0.00013% of range0.0100
52W High0.0100 USD
52W Low0.0001 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE176.86%
ROA-2959.69%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-8.13M $
CapEx (TTM)1.55K $
FCF Margin—
FCF Yield2913.37%
Net Debt-362.10K $
Net Debt/EBITDA0.04
Balance Sheet
Debt/Equity—
Current Ratio0.04
Quick Ratio0.03
Book Value/Sh-0.2380 USD
Cash/Share0.0090 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.42.08M
Float34.22M
Insiders0.00%
Institutions0.00%
Short Interest
Short Ratio0.2d
Short % Float0.25%
Short % Out.0.11%
Shares Short23.77K
Short (prev mo.)19.47K
Technical
SMA 500.0004 (-9.9%)
SMA 2000.0004 (-10.4%)
Beta31.83
S&P 52W Chg18.16%
Avg Vol (30d)357
Avg Vol (10d)2.80K
Technical Indicators
RSI (14)48.7
MACD-0.0000
MACD Signal-0.0000
MACD Hist.-0.0000
BB Upper0.0006 USD
BB Middle0.0004 USD
BB Lower0.0002 USD
BB Width84.35%
ATR (14)0.0000 USD
Vol Ratio (20d)0.89x